Literature DB >> 27132284

Diversity and Tropism of HIV-1 Rebound Virus Populations in Plasma Level After Treatment Discontinuation.

Maria M Bednar1, Blake M Hauser1, Shuntai Zhou1, Jeffrey M Jacobson2, Joseph J Eron3, Ian Frank4, Ronald Swanstrom5.   

Abstract

Human immunodeficiency virus-infected people discontinuing therapy experience a rebound in the virus level (hereafter, "rebound virus") from a persistent reservoir. We examined 10 samples from patients in AIDS Clinical Trials Group study A5068 with rebound virus, using single-genome amplification and Primer ID deep sequencing, to assess env genetic diversity of the virus population. Most rebound-virus populations showed significant diversity. All env examined required high levels of CD4 for entry, consistent with selection of replication in CD4(+) T cells. These results indicate that most people discontinuing therapy release a diverse population of virus and that this released virus has entry features of virus selected for replication in CD4(+) T cells, rather than in myeloid cells.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  HIV-1; genetic diversity; rebound virus; reservoir; tropism

Mesh:

Substances:

Year:  2016        PMID: 27132284      PMCID: PMC4936648          DOI: 10.1093/infdis/jiw172

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

Authors:  D Finzi; J Blankson; J D Siliciano; J B Margolick; K Chadwick; T Pierson; K Smith; J Lisziewicz; F Lori; C Flexner; T C Quinn; R E Chaisson; E Rosenberg; B Walker; S Gange; J Gallant; R F Siliciano
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

2.  HIV rebounds from latently infected cells, rather than from continuing low-level replication.

Authors:  Beda Joos; Marek Fischer; Herbert Kuster; Satish K Pillai; Joseph K Wong; Jürg Böni; Bernard Hirschel; Rainer Weber; Alexandra Trkola; Huldrych F Günthard
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-20       Impact factor: 11.205

3.  Quantification of entry phenotypes of macrophage-tropic HIV-1 across a wide range of CD4 densities.

Authors:  Sarah B Joseph; Kathryn T Arrildt; Adrienne E Swanstrom; Gretja Schnell; Benhur Lee; James A Hoxie; Ronald Swanstrom
Journal:  J Virol       Date:  2013-12-04       Impact factor: 5.103

4.  Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption.

Authors:  Meghan K Rothenberger; Brandon F Keele; Stephen W Wietgrefe; Courtney V Fletcher; Gregory J Beilman; Jeffrey G Chipman; Alexander Khoruts; Jacob D Estes; Jodi Anderson; Samuel P Callisto; Thomas E Schmidt; Ann Thorkelson; Cavan Reilly; Katherine Perkey; Thomas G Reimann; Netanya S Utay; Krystelle Nganou Makamdop; Mario Stevenson; Daniel C Douek; Ashley T Haase; Timothy W Schacker
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-23       Impact factor: 11.205

5.  Relationship of HIV reservoir characteristics with immune status and viral rebound kinetics in an HIV therapeutic vaccine study.

Authors:  Jonathan Z Li; Andrea Heisey; Hayat Ahmed; Hongying Wang; Lu Zheng; Mary Carrington; Terri Wrin; Robert T Schooley; Michael M Lederman; Daniel R Kuritzkes
Journal:  AIDS       Date:  2014-11-28       Impact factor: 4.177

6.  Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen.

Authors:  L H Ping; M S Cohen; I Hoffman; P Vernazza; F Seillier-Moiseiwitsch; H Chakraborty; P Kazembe; D Zimba; M Maida; S A Fiscus; J J Eron; R Swanstrom; J A Nelson
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

7.  Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

Authors:  J K Wong; M Hezareh; H F Günthard; D V Havlir; C C Ignacio; C A Spina; D D Richman
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

8.  Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection.

Authors:  Brandon F Keele; Elena E Giorgi; Jesus F Salazar-Gonzalez; Julie M Decker; Kimmy T Pham; Maria G Salazar; Chuanxi Sun; Truman Grayson; Shuyi Wang; Hui Li; Xiping Wei; Chunlai Jiang; Jennifer L Kirchherr; Feng Gao; Jeffery A Anderson; Li-Hua Ping; Ronald Swanstrom; Georgia D Tomaras; William A Blattner; Paul A Goepfert; J Michael Kilby; Michael S Saag; Eric L Delwart; Michael P Busch; Myron S Cohen; David C Montefiori; Barton F Haynes; Brian Gaschen; Gayathri S Athreya; Ha Y Lee; Natasha Wood; Cathal Seoighe; Alan S Perelson; Tanmoy Bhattacharya; Bette T Korber; Beatrice H Hahn; George M Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-19       Impact factor: 11.205

9.  Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays.

Authors:  David C Montefiori
Journal:  Curr Protoc Immunol       Date:  2005-01

10.  Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing.

Authors:  Jesus F Salazar-Gonzalez; Elizabeth Bailes; Kimmy T Pham; Maria G Salazar; M Brad Guffey; Brandon F Keele; Cynthia A Derdeyn; Paul Farmer; Eric Hunter; Susan Allen; Olivier Manigart; Joseph Mulenga; Jeffrey A Anderson; Ronald Swanstrom; Barton F Haynes; Gayathri S Athreya; Bette T M Korber; Paul M Sharp; George M Shaw; Beatrice H Hahn
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

View more
  12 in total

1.  Broadly neutralizing antibody-derived CAR T cells reduce viral reservoir in individuals infected with HIV-1.

Authors:  Bingfeng Liu; Wanying Zhang; Baijin Xia; Shuliang Jing; Yingying Du; Fan Zou; Rong Li; Lijuan Lu; Shaozhen Chen; Yonghong Li; Qifei Hu; Yingtong Lin; Yiwen Zhang; Zhangping He; Xu Zhang; Xiejie Chen; Tao Peng; Xiaoping Tang; Weiping Cai; Ting Pan; Linghua Li; Hui Zhang
Journal:  J Clin Invest       Date:  2021-10-01       Impact factor: 14.808

2.  Single Genome Sequencing of Expressed and Proviral HIV-1 Envelope Glycoprotein 120 (gp120) and nef Genes.

Authors:  David J Nolan; Susanna L Lamers; Rebecca Rose; James J Dollar; Marco Salemi; Michael S McGrath
Journal:  Bio Protoc       Date:  2017-06-20

3.  Estimating Initial Viral Levels during Simian Immunodeficiency Virus/Human Immunodeficiency Virus Reactivation from Latency.

Authors:  Mykola Pinkevych; Christine M Fennessey; Deborah Cromer; Martin Tolstrup; Ole S Søgaard; Thomas A Rasmussen; Brandon F Keele; Miles P Davenport
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

4.  Novel Transmitted/Founder Simian-Human Immunodeficiency Viruses for Human Immunodeficiency Virus Latency and Cure Research.

Authors:  Anya M Bauer; Widade Ziani; Emily Lindemuth; Leticia Kuri-Cervantes; Hui Li; Fang-Hua Lee; Meagan Watkins; Wenge Ding; Huanbin Xu; Ronald Veazey; Katharine J Bar
Journal:  J Virol       Date:  2020-03-31       Impact factor: 5.103

5.  Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption.

Authors:  Katharine J Bar; Michael C Sneller; Linda J Harrison; J Shawn Justement; Edgar T Overton; Mary E Petrone; D Brenda Salantes; Catherine A Seamon; Benjamin Scheinfeld; Richard W Kwan; Gerald H Learn; Michael A Proschan; Edward F Kreider; Jana Blazkova; Mark Bardsley; Eric W Refsland; Michael Messer; Katherine E Clarridge; Nancy B Tustin; Patrick J Madden; KaSaundra Oden; Sijy J O'Dell; Bernadette Jarocki; Andrea R Shiakolas; Randall L Tressler; Nicole A Doria-Rose; Robert T Bailer; Julie E Ledgerwood; Edmund V Capparelli; Rebecca M Lynch; Barney S Graham; Susan Moir; Richard A Koup; John R Mascola; James A Hoxie; Anthony S Fauci; Pablo Tebas; Tae-Wook Chun
Journal:  N Engl J Med       Date:  2016-11-09       Impact factor: 91.245

6.  Effective treatment of SIVcpz-induced immunodeficiency in a captive western chimpanzee.

Authors:  Hannah J Barbian; Raven Jackson-Jewett; Corrine S Brown; Frederic Bibollet-Ruche; Gerald H Learn; Timothy Decker; Edward F Kreider; Yingying Li; Thomas N Denny; Paul M Sharp; George M Shaw; Jeffrey Lifson; Edward P Acosta; Michael S Saag; Katharine J Bar; Beatrice H Hahn
Journal:  Retrovirology       Date:  2017-06-02       Impact factor: 4.602

7.  A single variant sequencing method for sensitive and quantitative detection of HIV-1 minority variants.

Authors:  Gurjit Sidhu; Layla Schuster; Lin Liu; Ryan Tamashiro; Eric Li; Taimour Langaee; Richard Wagner; Gary P Wang
Journal:  Sci Rep       Date:  2020-05-18       Impact factor: 4.379

Review 8.  Prospecting for an HIV vaccine.

Authors:  D M Brett-Major; T A Crowell; N L Michael
Journal:  Trop Dis Travel Med Vaccines       Date:  2017-03-24

Review 9.  Blocking Formation of the Stable HIV Reservoir: A New Perspective for HIV-1 Cure.

Authors:  Nilu Goonetilleke; Genevieve Clutton; Ron Swanstrom; Sarah B Joseph
Journal:  Front Immunol       Date:  2019-08-22       Impact factor: 7.561

Review 10.  HIV-1 Latency and Latency Reversal: Does Subtype Matter?

Authors:  Indra Sarabia; Alberto Bosque
Journal:  Viruses       Date:  2019-11-28       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.